▲ Peaking
Business
Why your health plan doesn’t cover GLP-1s, according to a top insurance exec
Insurers and employers are quietly rerouting patients to cash-based platforms for GLP-1 drugs—sparking access debates.
1 trends tracked about this subject — the full history, oldest to newest below.
Insurers and employers are quietly rerouting patients to cash-based platforms for GLP-1 drugs—sparking access debates.